Cargando…
Conditional activation of Pik3ca(H1047R) in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations
Oncogenic mutations in PIK3CA, which encodes the phosphoinositide-3-kinase (PI3K) catalytic subunit p110α, occur in ∼25% of human breast cancers. In this study, we report the development of a knock-in mouse model for breast cancer where the endogenous Pik3ca allele was modified to allow tissue-speci...
Autores principales: | Yuan, W, Stawiski, E, Janakiraman, V, Chan, E, Durinck, S, Edgar, K A, Kljavin, N M, Rivers, C S, Gnad, F, Roose-Girma, M, Haverty, P M, Fedorowicz, G, Heldens, S, Soriano, R H, Zhang, Z, Wallin, J J, Johnson, L, Merchant, M, Modrusan, Z, Stern, H M, Seshagiri, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3550595/ https://www.ncbi.nlm.nih.gov/pubmed/22370636 http://dx.doi.org/10.1038/onc.2012.53 |
Ejemplares similares
-
S100a4 upregulation in Pik3caH1047R;Trp53R270H;MMTV-Cre-driven mammary tumors promotes metastasis
por: Yuan, Wenlin, et al.
Publicado: (2019) -
Identification of effective natural PIK3CA H1047R inhibitors by computational study
por: Liu, Naimeng, et al.
Publicado: (2021) -
Embryonic lethality and defective mammary gland development of activator‐function impaired conditional knock‐in Erbb3
(
V943R
) mice
por: Senger, Kate, et al.
Publicado: (2020) -
Investigating the Structure and Dynamics of the PIK3CA Wild-Type and H1047R Oncogenic Mutant
por: Gkeka, Paraskevi, et al.
Publicado: (2014) -
PIK3CA(H1047R)-induced paradoxical ERK activation results in resistance to BRAF(V600E) specific inhibitors in BRAF(V600E) PIK3CA(H1047R) double mutant thyroid tumors
por: Roelli, Matthias A., et al.
Publicado: (2017)